Crescent Biopharma Return on Net Operating Assets Trends

Crescent Biopharma, Inc. (CBIO)

11.85 -0.37 (-3.03%) USD | NASDAQ | Dec 19, 16:00

11.88 +0.03 (+0.25%) After-Hours: 20:00

View Return on Net Operating Assets for CBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

XOMA Royalty Corp.	Upgrade
Viridian Therapeutics, Inc.	Upgrade
DiaMedica Therapeutics, Inc.	Upgrade
Denali Therapeutics, Inc.	Upgrade
Praxis Precision Medicines, Inc.	Upgrade